| Shadan Mansoor, MD | |
|
11805 South Fwy Ste 201, Burleson, TX 76028-7220 | |
| (817) 551-5312 | |
| Not Available |
| Full Name | Shadan Mansoor |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 35 Years |
| Location | 11805 South Fwy Ste 201, Burleson, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679523088 | NPI | - | NPPES |
| 8M2993 | Other | TX | BCBS |
| 1736241-01 | Medicaid | TX | |
| 1736241-02 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | M1226 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Huguley Hospital Fort Worth South | Burleson, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology-hematology Consultants Pa | 5496646382 | 56 |
News Archive
OncoVista Innovative Therapies, Inc., reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more efficacious cancer treatments with reduced or no toxicity.
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections
Conceptus Inc., developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound to confirm proper placement of Essure micro-inserts three months following the Essure procedure.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 6 days ago
| Entity Name | Oncology-hematology Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629021159 PECOS PAC ID: 5496646382 Enrollment ID: O20040322000664 |
News Archive
OncoVista Innovative Therapies, Inc., reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more efficacious cancer treatments with reduced or no toxicity.
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections
Conceptus Inc., developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound to confirm proper placement of Essure micro-inserts three months following the Essure procedure.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shadan Mansoor, MD Po Box 164009, Fort Worth, TX 76161-4009 Ph: (817) 759-7000 | Shadan Mansoor, MD 11805 South Fwy Ste 201, Burleson, TX 76028-7220 Ph: (817) 551-5312 |
News Archive
OncoVista Innovative Therapies, Inc., reported in a letter to shareholders that it is moving forward on its business plan to develop targeted, safer and more efficacious cancer treatments with reduced or no toxicity.
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections
Conceptus Inc., developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound to confirm proper placement of Essure micro-inserts three months following the Essure procedure.
A team of international scientists has demonstrated that therapeutic inhibition of a transcriptional regulator BRD2, required for the endogenous expression of angiotensin-converting enzyme 2 (ACE2), can potentially suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv* preprint server.
› Verified 6 days ago
Dr. Anupama Chennupati, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy Ste 215, Burleson, TX 76028 Phone: 817-818-8433 Fax: 949-404-6343 | |
Timothy Denver Allen, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy Ste 203a, Burleson, TX 76028 Phone: 817-759-9759 | |
Dr. Prakash Hegde, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 11803 South Fwy Ste 201, Burleson, TX 76028 Phone: 817-293-4800 Fax: 817-293-4808 | |
Dr. Andrew Jordan Darwin, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11801 South Fwy, Burleson, TX 76028 Phone: 412-656-8215 | |
Wai Lynn Maung, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11801 South Fwy, Burleson, TX 76028 Phone: 817-293-9110 | |
Dr. Dayaker Gagadam, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy, Suite 208, Burleson, TX 76028 Phone: 817-293-3000 Fax: 817-293-3291 | |
Shirisha Peddi, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11801 South Fwy, Burleson, TX 76028 Phone: 817-568-5955 |